Home » Newsletters » BioWorld

BioWorld

May 20, 1998

View Archived Issues

ImClone Begins Phase III Trial Of BEC2 Cancer Vaccine

Other News To Note

After More Than A Year, FDA May Get New Chief This Week

COR's Integrilin Joins 2 Others In Battle For Anti-Platelet Market

Genetics Institute's ReFacto Under Review In U.S., Europe

Signal Seeking $30M In IPO For Gene Regulating Drugs

Stroke Trial Halt Surprises Scios; Stock Drops Nearly 14 Percent